BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 34663322)

  • 1. A novel prognostic cancer-related lncRNA signature in papillary renal cell carcinoma.
    Chen B; Dong D; Yao Q; Zou Y; Hu W
    Cancer Cell Int; 2021 Oct; 21(1):545. PubMed ID: 34663322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival prediction of kidney renal papillary cell carcinoma by comprehensive LncRNA characterization.
    Lan H; Zeng J; Chen G; Huang H
    Oncotarget; 2017 Dec; 8(67):110811-110829. PubMed ID: 29340018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A nomogram based on 9-lncRNAs signature for improving prognostic prediction of clear cell renal cell carcinoma.
    Jiang W; Guo Q; Wang C; Zhu Y
    Cancer Cell Int; 2019; 19():208. PubMed ID: 31404170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and Validation of a Novel Stemness-Index-Related Long Noncoding RNA Signature for Breast Cancer Based on Weighted Gene Co-Expression Network Analysis.
    Qian D; Qian C; Ye B; Xu M; Wu D; Li J; Li D; Yu B; Tao Y
    Front Genet; 2022; 13():760514. PubMed ID: 35273635
    [No Abstract]   [Full Text] [Related]  

  • 5. A 15-long non-coding RNA signature to improve prognosis prediction of cervical squamous cell carcinoma.
    Mao X; Qin X; Li L; Zhou J; Zhou M; Li X; Xu Y; Yuan L; Liu QN; Xing H
    Gynecol Oncol; 2018 Apr; 149(1):181-187. PubMed ID: 29525275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel seven-lncRNA signature for prognosis prediction in hepatocellular carcinoma.
    Yan J; Zhou C; Guo K; Li Q; Wang Z
    J Cell Biochem; 2019 Jan; 120(1):213-223. PubMed ID: 30206981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cuproptosis-Related LncRNA-Based Prediction of the Prognosis and Immunotherapy Response in Papillary Renal Cell Carcinoma.
    Pang Y; Wang Y; Zhou X; Ni Z; Chen W; Liu Y; Du W
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a RNA-Seq Based 8-Long Non-Coding RNA Signature Predicting Survival in Esophageal Cancer.
    Fan Q; Liu B
    Med Sci Monit; 2016 Dec; 22():5163-5172. PubMed ID: 28028307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioinformatics profiling integrating a four immune-related long non-coding RNAs signature as a prognostic model for papillary renal cell carcinoma.
    Liu Y; Gou X; Wei Z; Yu H; Zhou X; Li X
    Aging (Albany NY); 2020 Jul; 12(15):15359-15373. PubMed ID: 32716909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Four-lncRNA immune prognostic signature for triple-negative breast cancer Running title: Immune lncRNAs predict prognosis of TNBC.
    Li YX; Wang SM; Li CQ
    Math Biosci Eng; 2021 May; 18(4):3939-3956. PubMed ID: 34198419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long noncoding RNA RP11-547D24.1 regulates proliferation and migration in papillary thyroid carcinoma: Identification and validation of a novel long noncoding RNA through integrated analysis of TCGA database.
    Guo K; Chen L; Wang Y; Qian K; Zheng X; Sun W; Sun T; Wu Y; Wang Z
    Cancer Med; 2019 Jun; 8(6):3105-3119. PubMed ID: 31044550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High CENPA expression in papillary renal cell carcinoma tissues is associated with poor prognosis.
    Li J; Li Q; Yuan Y; Xie Y; Zhang Y; Zhang R
    BMC Urol; 2022 Sep; 22(1):157. PubMed ID: 36163007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel Long Non-coding RNA Markers for Prognostic Prediction of Patients with Bladder Cancer.
    Li WX; Zhang YL
    Chin Med Sci J; 2020 Sep; 35(3):239-247. PubMed ID: 32972501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A seven-lncRNA signature for predicting prognosis in breast carcinoma.
    Xu M; Chen Z; Lin B; Zhang S; Qu J
    Transl Cancer Res; 2021 Sep; 10(9):4033-4046. PubMed ID: 35116701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Novel Ferroptosis-Related lncRNA Signature for Prognosis Prediction in Patients with Papillary Renal Cell Carcinoma.
    Dang R; Jin M; Nan J; Jiang X; He Z; Su F; Li D
    Int J Gen Med; 2022; 15():207-222. PubMed ID: 35023959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-wide mutation profiling and related risk signature for prognosis of papillary renal cell carcinoma.
    Zhang C; Zheng Y; Li X; Hu X; Qi F; Luo J
    Ann Transl Med; 2019 Sep; 7(18):427. PubMed ID: 31700863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening key lncRNAs with diagnostic and prognostic value for head and neck squamous cell carcinoma based on machine learning and mRNA-lncRNA co-expression network analysis.
    Hu Y; Guo G; Li J; Chen J; Tan P
    Cancer Biomark; 2020; 27(2):195-206. PubMed ID: 31815689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognosis of clear cell renal cell carcinoma (ccRCC) based on a six-lncRNA-based risk score: an investigation based on RNA-sequencing data.
    Zeng JH; Lu W; Liang L; Chen G; Lan HH; Liang XY; Zhu X
    J Transl Med; 2019 Aug; 17(1):281. PubMed ID: 31443717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of a novel six-long non-coding RNA signature predicting survival of colorectal cancer patients.
    Fan Q; Liu B
    J Cell Biochem; 2018 Apr; 119(4):3574-3585. PubMed ID: 29227531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and Validation of a Ferroptosis-Related Signature for Predicting Prognosis and Immune Microenvironment in Papillary Renal Cell Carcinoma.
    Da Q; Ren M; Huang L; Qu J; Yang Q; Xu J; Ma Q; Mao X; Cai Y; Zhao D; Luo J; Yan Z; Sun L; Ouyang K; Zhang X; Han Z; Liu J; Wang T
    Int J Gen Med; 2022; 15():2963-2977. PubMed ID: 35313551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.